Deals Shaping The Medical Industry, March 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type –Acquisition, Alliance, or Financing.

Diagnostics company Viracor-IBT Laboratories Inc. has acquired Cylex Inc., a privately held firm that sells an immune system function test. The purchase price was not disclosed, but industry sources report that the value of the deal is less than half of the $32mm in venture funding that was put into Cylex since inception. (Feb.)

Cylex was formed in 1992 as Biotechnology Transfer Inc. The company only ever developed and sold one product, the ImmuKnow...

More from Deal-Making

More from In Vivo